[HTML][HTML] Polymeric microspheres for medical applications

K Saralidze, LH Koole, MLW Knetsch - Materials, 2010 - mdpi.com
Synthetic polymeric microspheres find application in a wide range of medical applications.
Among other applications, microspheres are being used as bulking agents, embolic-or drug …

Uterine fibroids in menopause and perimenopause

M Ulin, M Ali, ZT Chaudhry, A Al-Hendy, Q Yang - Menopause, 2020 - journals.lww.com
Uterine fibroids (UFs) are benign tumors that arise from a single genetically altered
mesenchymal stem cell under the influence of gonadal hormones. UFs are the most …

[HTML][HTML] Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas

V Grigorieva, M Chen-Mok, M Tarasova, A Mikhailov - Fertility and sterility, 2003 - Elsevier
OBJECTIVE: This study was designed to evaluate the potential usefulness of the
levonorgestrel-releasing intrauterine system (LNG IUS) in treating women with uterine …

[HTML][HTML] Management of uterine fibroids

KE Hartmann, C Fonnesbeck, T Surawicz… - 2019 - europepmc.org
Management of Uterine Fibroids - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

Modern management of uterine fibroids

BS Levy - Acta obstetricia et gynecologica Scandinavica, 2008 - Taylor & Francis
Uterine fibroids are the most common tumor of the reproductive tract in women of
reproductive age. Although they are benign tumors that are often asymptomatic, uterine …

[HTML][HTML] A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

K Chwalisz, L Larsen, C Mattia-Goldberg, A Edmonds… - Fertility and sterility, 2007 - Elsevier
OBJECTIVE: To determine efficacy and safety of asoprisnil in patients with leiomyomata.
DESIGN: Phase 2, multicenter, prospective, randomized, double-blind, placebo-controlled …

An image‐guided high intensity focused ultrasound device for uterine fibroids treatment

AH Chan, VY Fujimoto, DE Moore, RW Martin… - Medical …, 2002 - Wiley Online Library
A high intensity focused ultrasound (HIFU) device was developed for treating uterine fibroid
tumors. This prototype device enables image‐guided therapy by aligning a commercially …

Danazol for uterine fibroids

L Ke, K Yang, CM Li, J Li - Cochrane Database of Systematic …, 2009 - cochranelibrary.com
Background Uterine fibroids (myomas, fibromyomas, leiomyomas) are the most common
benign tumours of the female genital tract. Danazol, a synthetic isoxazole derivative …

Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: Mid-term outcomes of 36 patients treated with the Sonalleve system

AC Thiburce, N Frulio, A Hocquelet… - International Journal …, 2015 - Taylor & Francis
Objectives: This study sought to assess the mid-term efficacy of magnetic resonance-guided
high-intensity focused ultrasound (MRgFUS)(Sonalleve system) for uterine fibroids …

What are the total costs of surgical treatment for uterine fibroids?

GS Carls, DW Lee, RJ Ozminkowski… - Journal of women's …, 2008 - liebertpub.com
Objective: To investigate the direct and indirect costs of uterine fibroid (UF) surgery.
Methods: Data were obtained from the MarketScan Commercial Claims and Encounters …